Novel genetic advances in schizophrenia: an interview with Michael O’Donovan
BMC Medicine 2015, 13:181 (5 August 2015)
Michael O'Donovan, lead of the Schizophrenia Working Group of the Psychiatric Genomics Consortium, talks to us about the latest genetic advances in schizophrenia, discussing future directions and interactions between genes and the environment.
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications
BMC Medicine 2014, 12:98 (13 June 2014)
Prescribing of generic risperidone has decreased compared with other atypical antipsychotic drugs in Western Europe, but utilization and price of the drug vary across countries, suggesting a need for increased prescribing and reduced price.
Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia
BMC Medicine 2013, 11:127 (14 May 2013)
This article is part of collection:
Current Controversies in...
Towards a new psychiatry:...
Victoria Cosgrove and Trisha Suppes agree that boundaries between the diagnosis of bipolar disorder I, schizophrenia and schizoaffective disorder are preserved in the DSM-5 criteria, as there is not yet enough data to justify a continuous model of psychosis.